Direct-acting antivirals in hepatitis C virus (HCV)-infected and HCV/HIV-coinfected patients: real-life safety and efficacy

Evaluation of Drug-Drug Interactions Between Hepatitis C Antiviral Agents Ombitasvir, Paritaprevir/Ritonavir, and Dasabuvir and HIV-1 Protease Inhibitors

(2016) Amit Khatri et al.   CLINICAL INFECTIOUS DISEASES

Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection

(2016) Mark S. Sulkowski et al.   GASTROENTEROLOGY

The importance of resistance to direct antiviral drugs in HCV infection in clinical practice

(2016) Christoph Sarrazin   JOURNAL OF HEPATOLOGY

Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus

(2015)   HEPATOLOGY

Ombitasvir, Paritaprevir Co-dosed With Ritonavir, Dasabuvir, and Ribavirin for Hepatitis C in Patients Co-infected With HIV-1

(2015) Mark S. Sulkowski et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

High hepatic and extrahepatic mortality and low treatment uptake in HCV-coinfected persons in the Swiss HIV cohort study between 2001 and 2013

(2015) Helen Kovari et al.   JOURNAL OF HEPATOLOGY

EASL Recommendations on Treatment of Hepatitis C 2015

(2015)   JOURNAL OF HEPATOLOGY

Interferon-free, direct-acting antiviral therapy for chronic hepatitis C

(2015) J. A. Gutierrez et al.   JOURNAL OF VIRAL HEPATITIS

Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1

(2015) Susanna Naggie et al.   NEW ENGLAND JOURNAL OF MEDICINE

Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1

(2015) David L. Wyles et al.   NEW ENGLAND JOURNAL OF MEDICINE

VirVarSeq: a low-frequency virus variant detection pipeline for Illumina sequencing using adaptive base-calling accuracy filtering

(2014) Bie M.P. Verbist et al.   BIOINFORMATICS

Telaprevir for HIV/Hepatitis C Virus-Coinfected Patients Failing Treatment With Pegylated Interferon/Ribavirin (ANRS HC26 TelapreVIH): An Open-Label, Single-Arm, Phase 2 Trial

(2014) L. Cotte et al.   CLINICAL INFECTIOUS DISEASES

Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection

(2014) Mark S. Sulkowski et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Management of anemia induced by triple therapy in patients with chronic hepatitis C: Challenges, opportunities and recommendations

(2013) Manuel Romero-Gómez et al.   JOURNAL OF HEPATOLOGY

Boceprevir versus placebo with pegylated interferon alfa-2b and ribavirin for treatment of hepatitis C virus genotype 1 in patients with HIV: a randomised, double-blind, controlled phase 2 trial

(2013) Mark Sulkowski et al.   LANCET INFECTIOUS DISEASES

Peginterferon alfa-2a Plus Ribavirin for HIV-HCV Genotype 1 Coinfected Patients: A Randomized International Trial

(2012) Maribel Rodriguez-Torres et al.   HIV CLINICAL TRIALS

Relationship of Liver Disease Stage and Antiviral Therapy With Liver-Related Events and Death in Adults Coinfected With HIV/HCV

(2012) Berkeley N. Limketkai et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical management of drug–drug interactions in HCV therapy: Challenges and solutions

(2012) David Burger et al.   JOURNAL OF HEPATOLOGY

Hepatitis C Virus Transmission Bottlenecks Analyzed by Deep Sequencing

(2010) G. P. Wang et al.   JOURNAL OF VIROLOGY

Meta‐Analysis: Increased Mortality Associated with Hepatitis C in HIV‐Infected Persons Is Unrelated to HIV Disease Progression

(2009) Ting‐Yi Chen et al.   CLINICAL INFECTIOUS DISEASES